Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Undbio Logo
Undbio Growth Score
82
CB Rank
1066399
Heat Score
40
Undbio develops pharmaceuticals to treat diabetes, cancer, and immunology related diseases.
Founded
obfuscation
Private Seongnam, Kyonggi-do, South Korea11-50 undbio.com
Biotechnology
Medical
Pharmaceutical
Overview

Undbio
Growth Score
82
Heat Score
40

Growth Score82
-3 pts
in past quarter
Heat Score 40
-16 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Undbio

CB Rank
1066399
Undbio develops pharmaceuticals to treat diabetes, cancer, and immunology related diseases.
Founded
obfuscation
Private Seongnam, Kyonggi-do, South Korea11-50 undbio.com
Biotechnology
Medical
Pharmaceutical

Details

Legal Name Undbio Co., Ltd
Operating Status Active
Company Type For Profit
Phone Number +82-31853-6409
Contact Email info@undbio.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Insulin and Insulin Analog Products
Pharmaceutical products including insulin and insulin analogs designed to treat diabetes by regulating blood sugar levels.
Biosimilar Monoclonal Antibodies (mAb) Production Technology
Development and production technology for biosimilar monoclonal antibodies targeting cancer and immunology-related diseases.

Research & Development

Undbio is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Contacts 2
News

News and Press

News•Nov 23, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

85
-41.78%
 in past month

Active Website Tech Count

8Undbio is actively using 8 technologies for its website, according to BuiltWith. These include SPF, Euro, and  nginx.

Total IP

5The intellectual property of Undbio includes 3 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Undbio has registered 2 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Undbio's headquarters? Undbio is located in Seongnam, Kyonggi-do, South Korea.Who are Undbio's competitors? Alternatives and possible competitors to Undbio may include Eli Lilly, Pfizer, and  Samsung Bioepis.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(6ec160d 1)
|